Navigation Links
DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm

NEW DELHI, October 7 /PRNewswire/ -- DBMS Consulting announced that it has successfully completed deployment of Oracle Life Sciences Applications (OHSA) Suite and Oracle E-Business Suite (EBS) for SIRO Clinpharm, one of the leading global CROs headquartered in Thane, India. OHSA offers fully automated capabilities in management of clinical trial process, clinical trial data and global adverse event reporting.

After this implementation, SIRO gains complete operational functionality of the Oracle Health Sciences Application. SIRO has already gone live with the industry standard Oracle Clinical and Oracle RDC, integrated with Thesaurus Management System for its Clinical Data Management Services in January 2009.

The OHSA Suite product portfolio for SIRO is comprised of Siebel Clinical Trial Management System 8.0 (CTMS), Adverse Events Reporting System 4.6 (AERS), Oracle Clinical 4.5.3 (OC), Remote Data Capture 4.5.3 (RDC) and Thesaurus Management System 4.6 (TMS).

The entire implementation process of the OHSA Suite at SIRO was supported by DBMS Consulting, Inc. who is also a preferred partner of OHSA Products. With active support from SIRO's top management, DBMS Consulting, Inc. was able to complete the successful implementation on time. In continuation of the strong association between the two companies, SIRO has also awarded the support contract for entire OHSA Suite to DBMS Consulting for the next 3 years. DBMS has created a dedicated infrastructure to support SIRO in this regard.

"We are extremely happy with the way DBMS Consulting has implemented the OHSA for SIRO . Their competitiveness comes from the teams' domain expertise, flexibility in delivery and price effectiveness. Our continuation of a 3 year OHS support contract is an endorsement of DBMS Consulting's Global implementation and support capabilities." commented Dr. Ajit Nair, President for SIRO's India Operations.

"The support contract is the extension of the successful implementation of OHS (Oracle Health Sciences) Suite of applications and Oracle Financials in SIRO. DBMS has a very strong team who has the capability to meet all business requirements in Life Sciences Industry. We had gone beyond the initial scope of work to fulfill the expectations of the business to make this project more than a success" commented Raminder S. Sachdeva- Director, Projects- DBMS Consulting India Pvt. Ltd.

SIRO plans to roll out the OHSA Suite to its European operations soon to have the system working in all geographies in which the company has operations.

About DBMS Consulting Inc

DBMS Consulting is a global organisation which is specialised in the implementation of the Oracle Health Sciences (OHS) Applications and the Oracle E-Business Suite (EBS) Applications for Pharmaceuticals, CROs, Biotechs, Medical Device Companies, Academic Institutes and Government Institutes.

Incorporated in 1997, DBMS Consulting currently provides Oracle-related Health Sciences implementation and deployment services and supports to 20+ companies at any given time, and has performed implementations for over 60+ customers, with over 100+ installations and deployments of the Oracle Health Sciences solutions. These customers include global multinational firms, as well as APAC and India-based organisations."


    News published on website:

About SIRO Clinpharm

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials for the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel, Germany, Romania, Estonia and Greece. SIRO has recently opened offices in Czech Republic & Spain. For more information, visit

(*All Oracle products and product names are the registered international trademarks of Oracle Corporation).

    For India
    Raminder Singh Sachdeva
    m: +91-96500-31177 | o: +91-124-4696970 | f: +91-124-4696914

    For APAC
    Dr. Letian Liu
    m: +86-13402124879

    For USA & Europe
    m: +1-8609835848

SOURCE DBMS Consulting India Pvt. Ltd.

SOURCE DBMS Consulting India Pvt. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
8. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
9. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
10. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
11. Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
Breaking Medicine News(10 mins):